CY1113336T1 - Χρηση του gdf-5 για τη βελτιωση ή την διατηρηση της οψης του δερματος - Google Patents

Χρηση του gdf-5 για τη βελτιωση ή την διατηρηση της οψης του δερματος

Info

Publication number
CY1113336T1
CY1113336T1 CY20121101079T CY121101079T CY1113336T1 CY 1113336 T1 CY1113336 T1 CY 1113336T1 CY 20121101079 T CY20121101079 T CY 20121101079T CY 121101079 T CY121101079 T CY 121101079T CY 1113336 T1 CY1113336 T1 CY 1113336T1
Authority
CY
Cyprus
Prior art keywords
gdf
eye
maintain
improve
compositions
Prior art date
Application number
CY20121101079T
Other languages
English (en)
Inventor
Jens Pohl
Original Assignee
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh filed Critical Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh
Publication of CY1113336T1 publication Critical patent/CY1113336T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Η παρούσα εφεύρεση κατευθύνεται προς νέες μεθόδους και συνθέσεις, οι οποίες περιέχουν πρωτεΐνες του αυξητικού παράγοντα. Οι αναφερθείσες συνθέσεις έχουν σχεδιαστεί ειδικά για την βελτιστοποίηση της ποσότητας των σημαντικών δοκιμών στοιχείων των ιστών των θηλαστικών. Η εφεύρεση είναι ιδιαίτερα χρήσιμη για την παρουσίαση και την βελτίωση της όψης του δερματικού ιστού.
CY20121101079T 2007-01-25 2012-11-12 Χρηση του gdf-5 για τη βελτιωση ή την διατηρηση της οψης του δερματος CY1113336T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07001658 2007-01-25
EP08707263A EP2121142B1 (en) 2007-01-25 2008-01-24 Use of gdf-5 for the improvement or maintenance of dermal appearance

Publications (1)

Publication Number Publication Date
CY1113336T1 true CY1113336T1 (el) 2016-06-22

Family

ID=39323767

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121101079T CY1113336T1 (el) 2007-01-25 2012-11-12 Χρηση του gdf-5 για τη βελτιωση ή την διατηρηση της οψης του δερματος

Country Status (11)

Country Link
US (1) US20100047299A1 (el)
EP (1) EP2121142B1 (el)
AU (1) AU2008209069B2 (el)
CY (1) CY1113336T1 (el)
DK (1) DK2121142T3 (el)
ES (1) ES2402672T3 (el)
HR (1) HRP20120698T1 (el)
PL (1) PL2121142T3 (el)
PT (1) PT2121142E (el)
SI (1) SI2121142T1 (el)
WO (1) WO2008089987A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945872B2 (en) 2013-01-25 2015-02-03 Warsaw Orthopedic, Inc. Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
US9051389B2 (en) 2013-01-25 2015-06-09 Warsaw Orthopedic, Inc. Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5)
US9359417B2 (en) 2013-01-25 2016-06-07 Warsaw Orthopedic, Inc. Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
US8956829B2 (en) 2013-01-25 2015-02-17 Warsaw Orthopedic, Inc. Human recombinant growth and differentiaton factor-5 (rhGDF-5)
US9169308B2 (en) 2013-01-25 2015-10-27 Warsaw Orthopedic, Inc. Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies
DE102013224627A1 (de) * 2013-11-29 2015-06-03 Andreas Lauterbach Pharmazeutische Formulierung mit Lipidmikropartikeln und Herstellungsverfahren
BR112017013696B1 (pt) 2014-12-23 2024-01-02 Avon Products, Inc Método para diminuir o aparecimento de sinais dermatológicos do envelhecimento

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067637B1 (en) * 1992-02-12 2006-06-27 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Antibody or antibody fragments specific for a protein of the TGF-β family
CZ287715B6 (en) * 1992-02-12 2001-01-17 Bioph Biotech Entw Pharm Gmbh DNA sequence, recombinant DNA molecule containing thereof, process for preparing protein from the group of TGF-beta substances, pharmaceutical preparation containing such protein, antibody or fragment thereof and its use
US6120760A (en) * 1992-02-12 2000-09-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Growth/differentiation factors of the TGF-β family
IL110589A0 (en) 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
US6764994B1 (en) * 1993-08-10 2004-07-20 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Growth/differential factor of the TGF-B family
BR9608019A (pt) * 1995-04-19 1999-11-30 Hoechst Japan Uma nova proteína e um processo para a preparação da mesma'
JPH09143093A (ja) * 1995-11-17 1997-06-03 Hoechst Japan Ltd 軟骨・骨誘導性修復用材料
AU734312B2 (en) * 1996-03-22 2001-06-07 General Hospital Corporation, The Administration of polypeptide growth factors following central nervous system ischemia or trauma
DE19647853A1 (de) * 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
JPH11335398A (ja) * 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
EP1074620A1 (en) * 1999-08-06 2001-02-07 HyGene AG Monomeric protein of the TGF-beta family
EP1011712B1 (en) 1997-09-19 2004-02-11 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Combination of cytokines having neurotrophic activity
AU2002257703A1 (en) * 2001-03-23 2002-10-08 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders
US20020081324A1 (en) 2002-01-22 2002-06-27 Twine Rebecca Wright Method of treating aging skin and wrinkles using a combination of growth factors that is commercially prepared or derived from one's own blood
EP1462126A1 (en) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Improved Osteoinductive Materials
WO2006105359A2 (en) * 2005-03-30 2006-10-05 Wyeth Methods for stimulating hair growth by administering bmps
US20070078290A1 (en) * 2005-09-30 2007-04-05 Esenaliev Rinat O Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues
US20070160562A1 (en) * 2006-01-06 2007-07-12 Brinkenhoff Michael C Delivery devices for hair-promoting cosmetic agent
US7741273B2 (en) * 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
EP1880731A1 (en) * 2006-07-18 2008-01-23 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Human growth and differentiation factor GDF-5

Also Published As

Publication number Publication date
AU2008209069B2 (en) 2014-03-06
DK2121142T3 (da) 2013-07-29
EP2121142B1 (en) 2013-04-03
AU2008209069A1 (en) 2008-07-31
US20100047299A1 (en) 2010-02-25
PT2121142E (pt) 2013-04-30
PL2121142T3 (pl) 2013-09-30
HRP20120698T1 (hr) 2013-09-30
SI2121142T1 (sl) 2012-12-31
ES2402672T3 (es) 2013-05-07
WO2008089987A1 (en) 2008-07-31
EP2121142A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
CY1113336T1 (el) Χρηση του gdf-5 για τη βελτιωση ή την διατηρηση της οψης του δερματος
CY1123907T1 (el) Συνθεσεις και μεθοδοι για ρυθμιση αυξητικων παραγοντων
CY1122964T1 (el) Ενωσεις πυριμιδινοδιονης εναντι καρδιακων παθησεων
CY1119853T1 (el) Χρηση στρωματικων βλαστοκυτταρων λαμβανομενων απο ιστο αδιποζης στην θεραπεια συριγγιου
CY1118143T1 (el) Ετεροκυκλικες ενωσεις χρησιμες ως αναστολεις της pdk1
CY1121989T1 (el) Φαρμακοτεχνικες μορφες αντισωματων
CY1117695T1 (el) Υψηλης συγγενειας ανθρωπινα αντισωματα κατα της ανθρωπινης αγγειοποιητινης-2
CY1119056T1 (el) Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna
CY1116405T1 (el) Ν1/ν2-λακταμικοι αναστολεις ακετυλο-coa καρβοξυλασης
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
SV2007002813A (es) Compuestos para la modulacion de la actividad del c-fms y/o el c-kit y sus usos aplicables
ECSP077180A (es) Compuestos, composiciones y métodos
PA8819201A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
CY1116627T1 (el) Παραγωγα μεταστινης και χρηση αυτων
DOP2011000198A (es) Compuestos y metodos de uso
CY1110962T1 (el) Τρικυκλικες ενωσεις και η χρηση τους ως διαμορφωτες του υποδοχεα γλυκοκορτικοειδων
GT200600143A (es) Fenilacetamidas apropiadas como inhibidores de la proteina kinasa
CO6300954A2 (es) Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE525033T1 (de) Optische sonde zur abgabe von licht
DOP2013000212A (es) Formas cristalinas del dimetoxi-docetaxel y sus procedimientos de preparacion
UY32859A (es) Compuestos y composiciones como inhibidores de cinasa de proteina
CY1117745T1 (el) Ετεροκυκλικες ενωσεις και χρηση αυτων ως ρυθμιστες υποδοχεα τυπου iii κινασων τυροσινης
CR20160475A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
DOP2010000351A (es) Activadores de glucoquinasa